Clinical experience with high-flow nasal cannulas for coronavirus disease 2019 patients in Japan

Respir Investig. 2021 Jul;59(4):569-572. doi: 10.1016/j.resinv.2021.02.011. Epub 2021 Mar 26.

Authors

Takashi Katsuno¹, Manabu Suzuki², Masayuki Hojo², Junko Terada², Keiji Nakamura³, Tetsuya Suzuki³, Yusuke Miyazato³, Haruhito Sugiyama²

Affiliations

¹ Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan. Electronic address: takatsuno@hosp.ncgm.go.jp.
² Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan.
³ Department of Infectious Disease, Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.

No abstract available

Publication types

Letter

MeSH terms

Aged
COVID-19 / therapy*
Cannula*
Cross Infection / prevention & control
Female
Humans
Hyperbaric Oxygenation / methods*
Intubation, Intratracheal / statistics & numerical data
Japan
Male
Middle Aged